Maximilian B. MacPherson

1.7k total citations
42 papers, 1.2k citations indexed

About

Maximilian B. MacPherson is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Maximilian B. MacPherson has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Maximilian B. MacPherson's work include Occupational and environmental lung diseases (31 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers) and Pleural and Pulmonary Diseases (5 papers). Maximilian B. MacPherson is often cited by papers focused on Occupational and environmental lung diseases (31 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers) and Pleural and Pulmonary Diseases (5 papers). Maximilian B. MacPherson collaborates with scholars based in United States, Netherlands and Austria. Maximilian B. MacPherson's co-authors include Arti Shukla, Brooke T. Mossman, Jedd Hillegass, Stacie L. Beuschel, Harvey I. Pass, Joyce K. Thompson, Chad Steele, Pamela M. Vacek, Naomi K. Fukagawa and Kelly J. Butnor and has published in prestigious journals such as Nature Communications, The Journal of Immunology and PLoS ONE.

In The Last Decade

Maximilian B. MacPherson

41 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maximilian B. MacPherson United States 24 555 429 165 164 149 42 1.2k
Masahiro Ishizuka Japan 20 639 1.2× 338 0.8× 149 0.9× 61 0.4× 469 3.1× 84 1.2k
Evguenia Arguiri United States 25 326 0.6× 528 1.2× 74 0.4× 138 0.8× 107 0.7× 37 1.5k
Shinya Akatsuka Japan 25 815 1.5× 1.1k 2.6× 293 1.8× 228 1.4× 201 1.3× 65 2.5k
Dongdong Zheng China 17 229 0.4× 724 1.7× 111 0.7× 138 0.8× 227 1.5× 51 1.6k
Federica Saletta Australia 19 266 0.5× 779 1.8× 64 0.4× 98 0.6× 105 0.7× 38 1.5k
Licun Wu Canada 27 909 1.6× 565 1.3× 56 0.3× 237 1.4× 110 0.7× 68 1.8k
Jiaming Xie China 13 186 0.3× 515 1.2× 60 0.4× 117 0.7× 105 0.7× 35 977
Xiaoyan Zou China 15 130 0.2× 265 0.6× 205 1.2× 112 0.7× 78 0.5× 26 866
Meili Shen China 17 108 0.2× 357 0.8× 137 0.8× 128 0.8× 183 1.2× 51 1.1k
Yutaro Mori Japan 27 246 0.4× 1.1k 2.6× 148 0.9× 258 1.6× 244 1.6× 95 2.4k

Countries citing papers authored by Maximilian B. MacPherson

Since Specialization
Citations

This map shows the geographic impact of Maximilian B. MacPherson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maximilian B. MacPherson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maximilian B. MacPherson more than expected).

Fields of papers citing papers by Maximilian B. MacPherson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maximilian B. MacPherson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maximilian B. MacPherson. The network helps show where Maximilian B. MacPherson may publish in the future.

Co-authorship network of co-authors of Maximilian B. MacPherson

This figure shows the co-authorship network connecting the top 25 collaborators of Maximilian B. MacPherson. A scholar is included among the top collaborators of Maximilian B. MacPherson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maximilian B. MacPherson. Maximilian B. MacPherson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Druso, Joseph E., Maximilian B. MacPherson, Shi Biao Chia, et al.. (2024). Endoplasmic Reticulum Oxidative Stress Promotes Glutathione-Dependent Oxidation of Collagen-1A1 and Promotes Lung Fibroblast Activation. American Journal of Respiratory Cell and Molecular Biology. 71(5). 589–602. 2 indexed citations
2.
Hondal, Robert J., Maximilian B. MacPherson, Sheryl L. White, et al.. (2023). Structural and functional fine mapping of cysteines in mammalian glutaredoxin reveal their differential oxidation susceptibility. Nature Communications. 14(1). 4550–4550. 9 indexed citations
3.
Aboushousha, Reem, Jos van der Velden, Nicholas Hamilton, et al.. (2023). Glutaredoxin attenuates glutathione levels via deglutathionylation of Otub1 and subsequent destabilization of system xC−. Science Advances. 9(37). eadi5192–eadi5192. 26 indexed citations
4.
Manuel, Allison M., Cheryl van de Wetering, Maximilian B. MacPherson, et al.. (2021). Dysregulation of Pyruvate Kinase M2 Promotes Inflammation in a Mouse Model of Obese Allergic Asthma. American Journal of Respiratory Cell and Molecular Biology. 64(6). 709–721. 13 indexed citations
5.
Thompson, Joyce K., Maximilian B. MacPherson, Stacie L. Beuschel, & Arti Shukla. (2017). Asbestos-Induced Mesothelial to Fibroblastic Transition Is Modulated by the Inflammasome. American Journal Of Pathology. 187(3). 665–678. 29 indexed citations
6.
MacPherson, Maximilian B., et al.. (2016). Actin polymerization plays a significant role in asbestos-induced inflammasome activation in mesothelial cells in vitro. Histochemistry and Cell Biology. 147(5). 595–604. 9 indexed citations
7.
Thompson, Joyce K., Alan L. Leggett, Maximilian B. MacPherson, et al.. (2015). Inflammasome Modulation by Chemotherapeutics in Malignant Mesothelioma. PLoS ONE. 10(12). e0145404–e0145404. 44 indexed citations
8.
Thompson, Joyce K., et al.. (2014). Curcumin: A Double Hit on Malignant Mesothelioma. Cancer Prevention Research. 7(3). 330–340. 50 indexed citations
9.
MacPherson, Maximilian B., et al.. (2014). CREB-Induced Inflammation Is Important for Malignant Mesothelioma Growth. American Journal Of Pathology. 184(10). 2816–2827. 26 indexed citations
10.
Sayan, Mutlay, Arti Shukla, Maximilian B. MacPherson, et al.. (2014). Extracellular Signal-Regulated Kinase 5 and Cyclic AMP Response Element Binding Protein Are Novel Pathways Inhibited by Vandetanib (ZD6474) and Doxorubicin in Mesotheliomas. American Journal of Respiratory Cell and Molecular Biology. 51(5). 595–603. 10 indexed citations
11.
Thompson, Joyce K., et al.. (2014). Asbestos modulates thioredoxin-thioredoxin interacting protein interaction to regulate inflammasome activation. Particle and Fibre Toxicology. 11(1). 24–24. 36 indexed citations
12.
Hillegass, Jedd, Maximilian B. MacPherson, Mutlay Sayan, et al.. (2013). Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells. Particle and Fibre Toxicology. 10(1). 39–39. 92 indexed citations
13.
Shukla, Arti, Trisha F. Barrett, Maximilian B. MacPherson, et al.. (2011). An Extracellular Signal–Regulated Kinase 2 Survival Pathway Mediates Resistance of Human Mesothelioma Cells to Asbestos-Induced Injury. American Journal of Respiratory Cell and Molecular Biology. 45(5). 906–914. 15 indexed citations
14.
Sabo‐Attwood, Tara, Maria E. Ramos‐Niño, Maximilian B. MacPherson, et al.. (2011). Osteopontin Modulates Inflammation, Mucin Production, and Gene Expression Signatures After Inhalation of Asbestos in a Murine Model of Fibrosis. American Journal Of Pathology. 178(5). 1975–1985. 49 indexed citations
15.
Hillegass, Jedd, Arti Shukla, Maximilian B. MacPherson, et al.. (2010). Inflammation precedes the development of human malignant mesotheliomas in a SCID mouse xenograft model. Annals of the New York Academy of Sciences. 1203(1). 7–14. 61 indexed citations
16.
Hillegass, Jedd, Arti Shukla, Maximilian B. MacPherson, et al.. (2010). Mechanisms of oxidative stress and alterations in gene expression by Libby six-mix in human mesothelial cells. Particle and Fibre Toxicology. 7(1). 26–26. 22 indexed citations
17.
Shukla, Arti, Jedd Hillegass, Maximilian B. MacPherson, et al.. (2010). Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin. Molecular Cancer. 9(1). 314–314. 63 indexed citations
18.
Shukla, Arti, et al.. (2008). A Protein Kinase Cδ-Dependent Protein Kinase D Pathway Modulates ERK1/2 and JNK1/2 Phosphorylation and Bim-Associated Apoptosis by Asbestos. American Journal Of Pathology. 174(2). 449–459. 26 indexed citations
19.
20.
Haegens, Astrid, Trisha F. Barrett, Joanna J. Gell, et al.. (2007). Airway Epithelial NF-κB Activation Modulates Asbestos-Induced Inflammation and Mucin Production In Vivo. The Journal of Immunology. 178(3). 1800–1808. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masahiro Ishizuka Breakdown of academic impact, for papers by Evguenia Arguiri Breakdown of academic impact, for papers by Shinya Akatsuka Breakdown of academic impact, for papers by Dongdong Zheng Breakdown of academic impact, for papers by Federica Saletta Breakdown of academic impact, for papers by Licun Wu Breakdown of academic impact, for papers by Jiaming Xie Breakdown of academic impact, for papers by Xiaoyan Zou Breakdown of academic impact, for papers by Meili Shen Breakdown of academic impact, for papers by Yutaro Mori
Rankless by CCL
2026